Literature DB >> 15968563

Measuring health-related utility: why the disparity between EQ-5D and SF-6D?

Stirling Bryan1, Louise Longworth.   

Abstract

There remains considerable disagreement concerning the preferred generic utility-based measure of health-related quality of life for use in constructing quality-adjusted life years. The recent appearance (in a published form) of a new measure, the SF-6D, has highlighted this issue. The SF-6D and EQ-5D have many similarities, but marked variation has been shown in the results generated by the two instruments. The study reported here is an exploration of why such divergent results exist. There are two possible explanations: variation in the descriptive component of the instruments and variation in the values applied to health states. The results suggest two important conclusions. First, the SF-6D can describe severe health states, including states that (according to the EQ-5D scoring algorithm) are viewed as worse than the state of being 'dead'. Second, much of the large discrepancy between the results generated using the two instruments appears to stem from very different valuations being placed on similar health states.

Mesh:

Year:  2005        PMID: 15968563     DOI: 10.1007/s10198-005-0299-9

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN: 1618-7598


  29 in total

Review 1.  Utility scores for different health states related to depression: individual participant data analysis.

Authors:  Spyros Kolovos; Judith E Bosmans; Johanna M van Dongen; Birre van Esveld; Dorcas Magai; Annemieke van Straten; Christina van der Feltz-Cornelis; Kirsten M van Steenbergen-Weijenburg; Klaas M Huijbregts; Harm van Marwijk; Heleen Riper; Maurits W van Tulder
Journal:  Qual Life Res       Date:  2017-03-04       Impact factor: 4.147

2.  Quantifying the decrement in utility from perceived side effects of combination antiretroviral therapies in patients with HIV.

Authors:  R Scott Braithwaite; Joseph Goulet; Ian Kudel; Joel Tsevat; Amy C Justice
Journal:  Value Health       Date:  2008-01-22       Impact factor: 5.725

3.  Comparing SF-6D and EQ-5D utilities across groups differing in health status.

Authors:  Nick Kontodimopoulos; Evelina Pappa; Angelos A Papadopoulos; Yannis Tountas; Dimitris Niakas
Journal:  Qual Life Res       Date:  2008-11-29       Impact factor: 4.147

4.  How consistent are health utility values?

Authors:  Pedro L Ferreira; Lara N Ferreira; Luis N Pereira
Journal:  Qual Life Res       Date:  2008-08-08       Impact factor: 4.147

5.  The impact of disease severity on EQ-5D and SF-6D utility discrepancies in chronic heart failure.

Authors:  Nick Kontodimopoulos; Michalis Argiriou; Nikolaos Theakos; Dimitris Niakas
Journal:  Eur J Health Econ       Date:  2010-05-15

6.  The classification systems of the EQ-5D, the HUI II and the SF-6D: what do they have in common?

Authors:  Uwe Konerding; Jörn Moock; Thomas Kohlmann
Journal:  Qual Life Res       Date:  2009-09-01       Impact factor: 4.147

7.  Preoperative risk assessment for bleeding and thromboembolism.

Authors:  Donald M Arnold; Julia Anderson; Clive Kearon
Journal:  BMJ       Date:  2009-09-03

8.  Valuing benefits to inform a clinical trial in pharmacy : do differences in utility measures at baseline affect the effectiveness of the intervention?

Authors:  Michela Tinelli; Mandy Ryan; Christine Bond; Anthony Scott
Journal:  Pharmacoeconomics       Date:  2013-02       Impact factor: 4.981

9.  Comparing the performance of the EQ-5D and SF-6D when measuring the benefits of alleviating knee pain.

Authors:  Garry R Barton; Tracey H Sach; Anthony J Avery; Michael Doherty; Claire Jenkinson; Kenneth R Muir
Journal:  Cost Eff Resour Alloc       Date:  2009-07-17

10.  Importance of sociodemographic and morbidity aspects in measuring health-related quality of life: performances of three tools: comparison of three questionnaire scores.

Authors:  Cecilia Quercioli; Gabriele Messina; Emanuela Barbini; Giovanni Carriero; Mara Fanì; Nicola Nante
Journal:  Eur J Health Econ       Date:  2008-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.